ClinicalTrials.gov
public full text
Public Domain
Alcohol Biosensor Monitoring for Alcoholic Liver Disease
Successful treatment of alcohol associated liver disease (AALD) depends primarily on abstinence from alcohol. The investigators propose a randomized clinical trial of alcohol biosensor monitoring for patients with alcohol associated liver disease to determine if monitoring with feedback on alcohol use patterns reduces alcohol consumption and improves outcomes.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Alcohol-driven phenotypic transition in MASLD and risk of liver-related events.#295486
- EUS Based Prevalence of Chronic Pancreatitis in Alcoholic Cirrhosis#827134
- Alcohol Labeling Study#471546
- Comparison of ALD, NASH, and Healthy Control Patients#1293284
- Acute intoxication with alcohol suppresses trauma-induced proinflammatory response and NF-κB signaling in the liver in synergy with A20 protein / Obada Alalman#921765
Record · ID 1383247
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive